Median Technologies Announces Design Completion of its iBiopsy® Lung Cancer Screening End-to-end CADe/CADx Software as Medical Device (SaMD) with Outstanding Sensitivity & Specificity Performance
iBiopsy® Lung Cancer Screening (LCS) CADe/CADx1outstanding performance reaches 94.7% sensitivity2 at 93.3% specificity3, based on…